Finerenone 10 mg Oral Tablet
RxNorm 2562816
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2562816 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: finerenone 10 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Finerenone 10 mg Oral Tablet
(Atom ID: 12655529)
PSNPrescribable
Prescribable Name (PSN):
Finerenone 10 mg Oral Tablet
(Atom ID: 12655538)
PTPrescribable
Designated preferred name (PT):
Finerenone 10 mg oral tablet
(Atom ID: 12725835)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely finerenone 10 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 12727223)
Patient Education
Finerenone
Finerenone is used to treat adults with chronic kidney disease (damage to the kidneys which may worsen over time and may cause the kidneys to stop working) due to type 2 diabetes. This treatment may reduce the risk of worsening kidney disease, needing to be hospitalized for heart failure, and life-threatening heart and blood vessel disease or a heart attack. Finerenone is in a class of medications called mineralocorticoid receptor (MR) antagonists. It works by blocking the activity of certain steroids made in the body that can damage the heart and kidneys.
[Learn More]
* Please review the disclaimer below.